| 8741938 |
Compounds that are useful for improving pharmacokinetics |
Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy P. Huang |
2014-06-03 |
$102,543,000 |
| 8653141 |
HIV protease inhibiting compounds |
Charles A. Flentge, Hui-Ju Chen, David A. DeGoey, William J. Flosi, David J. Grampovnik +8 more |
2014-02-18 |
$212,376,000 |
| 8524753 |
Compounds that are useful for improving pharmacokinetics |
Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy P. Huang |
2013-09-03 |
$128,422,000 |
| 8497275 |
HCV protease inhibitors and uses thereof |
Brian E. Green, David D. Anderson, Todd D. Bosse, Curt S. Cooper, Allan C. Krueger +10 more |
2013-07-30 |
$103,103,000 |
| 8426388 |
Prodrugs of HIV protease inhibitors |
David A. DeGoey, William J. Flosi, David J. Grampovnik, Dale J. Kempf, Xiu C. Wang |
2013-04-23 |
$130,010,000 |
| 8193227 |
HIV protease inhibiting compounds |
Charles A. Flentge, Hui-Ju Chen, David A. DeGoey, William J. Flosi, David J. Grampovnik +8 more |
2012-06-05 |
$27,392,000 |
| 7902203 |
Anti-infective agents |
John K. Pratt, David A. Betebenner, Pamela L. Donner, Brian E. Green, Dale J. Kempf +14 more |
2011-03-08 |
$24,368,000 |
| 7834043 |
HIV protease inhibiting compounds |
David A. DeGoey, Charles A. Flentge, William J. Flosi, David J. Grampovnik, Dale J. Kempf +4 more |
2010-11-16 |
$23,054,000 |
| 7786153 |
Compounds that are useful for improving pharmacokinetics |
Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy P. Huang |
2010-08-31 |
$28,144,000 |
| 7718633 |
Prodrugs of HIV protease inhibitors |
David A. DeGoey, William J. Flosi, David J. Grampovnik, Dale J. Kempf, Xiu C. Wang |
2010-05-18 |
$94,662,000 |
| 7696226 |
HIV protease inhibiting compounds |
John T. Randolph, Hui-Ju Chen, David A. DeGoey, Charles A. Flentge, William J. Flosi +5 more |
2010-04-13 |
$223,815,000 |
| 7538105 |
Anti-infective agents |
Douglas K. Hutchinson, John Bellettini, David A. Betebenner, Richard D. Bishop, Thomas B. Borchardt +20 more |
2009-05-26 |
$85,478,000 |
| 7517876 |
Anti-infective agents |
Peggy P. Huang, John T. Randolph, Douglas K. Hutchinson, Ming C. Yeung, Charles A. Flentge |
2009-04-14 |
$538,679,000 |
| 7378414 |
Anti-infective agents |
Douglas K. Hutchinson, John Bellettini, David A. Betebenner, Richard D. Bishop, Thomas B. Borchardt +20 more |
2008-05-27 |
$85,889,000 |
| 6831096 |
Inhibitors of neuraminidases |
Clarence J. Maring, Yu Gui Gu, Hui-Ju Chen, Yuanwei Chen, David A. DeGoey +26 more |
2004-12-14 |
$66,667,000 |
| 6455571 |
Inhibitors of neuraminidases |
Clarence J. Maring, Yu Gui Gu, Hui-Ju Chen, Yuanwei Chen, David A. DeGoey +26 more |
2002-09-24 |
$75,982,000 |
| 5834438 |
"4""-deoxyerythromycin derivatives" |
Paul A. Lartey, Ramin Faghih, Hugh N. Nellans |
1998-11-10 |
$118,972,000 |
| 5789591 |
Process for preparing 1-substituted 8-chloro-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester compounds |
Daniel Chu, David A. DeGoey, David J. Grampovnik, Paul A. Lartey, Christina L. Leone +2 more |
1998-08-04 |
$92,214,000 |
| 5773421 |
Antifungal fusacandins |
Lisa A. Alder, Marianna Jackson, Neal S. Burres, James B. McAlpine, Jill E. Hochlowski +2 more |
1998-06-30 |
$45,654,000 |
| 5696084 |
Amino-lipopetide antifungal agents |
Paul A. Lartey, Leping Li, Christina L. Leone, Sheela A. Thomas, Ming C. Yeung +2 more |
1997-12-09 |
$84,766,000 |
| 5654411 |
Process for preparing 4-deoxyerythromycin derivatives |
Paul A. Lartey, Ramin Faghih, Hugh N. Nellans |
1997-08-05 |
$56,454,000 |
| 5616740 |
Process for making 9-deoxotaxane compounds |
Clinton M. Yeung, Leping Li |
1997-04-01 |
$22,553,000 |
| 5594157 |
Process for making taxol derivatives |
Geewananda P. Gunawardana, James B. McAlpine |
1997-01-14 |
$55,437,000 |
| 5578579 |
"4""-deoxyerythromycin derivatives" |
Paul A. Lartey, Ramin Faghih, Hugh N. Nellans |
1996-11-26 |
$36,147,000 |
| 5530020 |
Taxol derivatives |
Geewananda P. Gunawardana, James B. McAlpine |
1996-06-25 |
$65,478,000 |
